The US Food and Drug Administration (FDA) has accepted for expedited review French pharma major Sanofi’s supplemental ...

The US Food and Drug Administration (FDA) has approved Rybelsus (oral semaglutide) for reducing the risk of major adverse ...

In 2014, I sat in a room at a “Genetic Networks” conference listening to Brendan Frey present his talk titled Decoding the ...

Danish allergy immunotherapy specialist ALK Abello has announced that EURneffy 2mg nasal adrenaline spray, the UK’s first ...

San Diego-based Rani Therapeutics Holdings, a biotherapeutics company focused on the oral delivery of biologics and drugs, ...

US biotech Exelixis has announced detailed results from STELLAR-303, a global Phase III pivotal trial evaluating ...

UK biotech Cyclana Bio has secured £5 million ($6.1 million) in pre-seed funding to advance its platform targeting women’s ...

A future-proof pharmaceutical policy requires a healthy balance between affordability, availability, and quality. The fact ...

Swedish Orphan Biovitrum, the Nordic biotech company also known as Sobi, today announced positive third-quarter 2025 ...

Swiss pharma giant Novartis yesterday presented positive new Pluvicto (lutetium (177Lu) vipivotide tetraxetan) data from the ...

CNS specialist Lundbeck and fellow Denmark based Contera Pharma today announced a strategic research collaboration aiming to ...

The US Food and Drug Administration (FDA) has approved Tezspire (tezepelumab-ekko) for the add-on maintenance treatment of ...